Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence (Q41572274)

3 October 2017

Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence (English)

1 reference

Jean-Charles Duclos-Vallée

3 October 2017

1 reference

11

Jean-Charles Duclos-Vallée

1 reference

3 October 2017

Laurence Bonhomme-Faivre

1 reference

ORCID Public Data File 2021

Anne-Marie Taburet

10

Anne-Marie Taburet

1 reference

3 October 2017

1

Audrey Coilly

1 reference

3 October 2017

9

Didier Samuel

1 reference

3 October 2017

Teresa Maria Antonini

7

Teresa Maria Antonini

1 reference

3 October 2017

Anne-Marie Roque-Afonso

8

Anne-Marie Roque-Afonso

1 reference

3 October 2017

Valérie Furlan

2

1 reference

3 October 2017

Bruno Roche

3

1 reference

3 October 2017

Caroline Barau

4

1 reference

3 October 2017

Coralie Noël

5

1 reference

3 October 2017

Laurence Bonhomme-Faivre

6

1 reference

3 October 2017

language of work or name

English

0 references

publication date

20 August 2012

1 reference

Antimicrobial Agents and Chemotherapy

3 October 2017

1 reference

3 October 2017

56

1 reference

3 October 2017

11

1 reference

3 October 2017

5728-5734

1 reference

Preliminary study of two antiviral agents for hepatitis C genotype 1.

3 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Boceprevir for previously treated chronic HCV genotype 1 infection

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Boceprevir for untreated chronic HCV genotype 1 infection

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Management of drug and food interactions with azole antifungal agents in transplant recipients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Drug interactions in transplant patients: what everyone should know

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Drug interactions should be evaluated in patients.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486528

Early histologic changes in fibrosing cholestatic hepatitis C

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22908172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22908172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22908172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.01151-12

1 reference

3 October 2017

1 reference

3 October 2017

1 reference